Asia Pacific Extracorporeal CO2 Removal Devices Market Size and Forecast (2021 - 2031)
The Asia Pacific Extracorporeal CO2 Removal Devices Market is projected to grow significantly, reaching an estimated US$ 42.1 million by 2031, up from US$ 25.3 million in 2024, reflecting a compound annual growth rate (CAGR) of 7.7% from 2025 to 2031. This growth is driven by increasing healthcare awareness, rising incidences of respiratory diseases, and advancements in healthcare infrastructure across the region.
Market Overview
The market is segmented by country, with China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific being the key players. China leads the market, holding the largest share and showing the highest growth potential. Japan and India are also significant contributors, benefiting from the rising prevalence of respiratory conditions and enhanced healthcare systems.
In terms of product segmentation, Extracorporeal CO2 Removal (ECCO2R) devices are the primary revenue generators, while disposables and consumables follow, albeit at a slower growth rate. Innovations in device technology, such as improved membranes and enhanced efficiency, are facilitating broader adoption in various healthcare settings.
Applications and End Users
ECCO2R technology is crucial in treating conditions like Acute Respiratory Distress Syndrome (ARDS) and Chronic Obstructive Pulmonary Disease (COPD). Hospitals are the primary end-users of these devices, while smaller clinics and centers are less common due to the technical complexities involved in ECCO2R.
The demand for ECCO2R devices is bolstered by several factors, including increased healthcare spending, urbanization leading to higher respiratory disease rates, and improved critical care infrastructure. However, challenges such as high costs, limited clinical evidence from extensive trials, and uneven distribution of trained personnel hinder widespread adoption. Currently, ECCO2R technology is primarily utilized in referral or academic medical centers rather than peripheral hospitals.
Strategic Insights
The aging population in the Asia Pacific region is a significant driver of the ECCO2R market. The World Health Organization (WHO) projects that the population aged 60 and over will rise from approximately 1.1 billion in 2023 to around 2.1 billion by 2050, constituting about 22% of the global population. This demographic shift correlates with an increase in chronic respiratory diseases, particularly among older adults who are more susceptible to acute respiratory failure.
Older patients often cannot tolerate the trauma of invasive mechanical ventilation, making ECCO2R a viable alternative or supplement. Studies indicate that ECCO2R can lead to fewer intubations and shorter durations of invasive mechanical ventilation, particularly beneficial for older patients with COPD.
Manufacturers are responding to these demographic and clinical needs through product innovations and clinical research. For instance, ALung Technologies' Hemolung RAS received FDA De Novo approval in 2024 as the first ECCO2R device for adults with reversible acute respiratory failure. This device operates at low blood flow rates, making it less stressful for elderly patients. Additionally, Baxter's PrismaLung+ is being tested for low-flow ECCO2R in ARDS patients.
Country Insights
China is emerging as the leading market for ECCO2R devices in the Asia Pacific region, driven by a rise in ARDS and COPD cases, worsened by air pollution and an aging population. Clinical studies in China have supported the use of ECCO2R in COVID-19-related ARDS cases, demonstrating its effectiveness in managing severe respiratory conditions.
Despite these advancements, challenges remain, including a lack of large-scale clinical trials and the concentration of ECCO2R use in high-tier hospitals. Factors such as device costs, facility requirements, and reimbursement policies are still uncertain, which may limit broader adoption.
Conclusion
In summary, the Asia Pacific ECCO2R devices market is on a robust growth trajectory, with significant contributions from China, Japan, and India. The increasing prevalence of respiratory diseases among the aging population, coupled with innovations in device technology, positions ECCO2R as a critical solution in respiratory care. However, for widespread adoption, further clinical validation, favorable reimbursement frameworks, and enhanced healthcare capacity are essential.
Key Players
Key players in the market include Terumo Corp, Medtronic Plc, Baxter International Inc, LivaNova Plc, Getinge AB, Fresenius Medical Care AG & Co KGaA, Eurosets SRL, Aferetica s.r.l., Medica S.p.A., and ESTOR S.P.A. These companies are focusing on expansion, product innovation, and strategic mergers and acquisitions to enhance their market presence.
Market Overview
The market is segmented by country, with China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific being the key players. China leads the market, holding the largest share and showing the highest growth potential. Japan and India are also significant contributors, benefiting from the rising prevalence of respiratory conditions and enhanced healthcare systems.
In terms of product segmentation, Extracorporeal CO2 Removal (ECCO2R) devices are the primary revenue generators, while disposables and consumables follow, albeit at a slower growth rate. Innovations in device technology, such as improved membranes and enhanced efficiency, are facilitating broader adoption in various healthcare settings.
Applications and End Users
ECCO2R technology is crucial in treating conditions like Acute Respiratory Distress Syndrome (ARDS) and Chronic Obstructive Pulmonary Disease (COPD). Hospitals are the primary end-users of these devices, while smaller clinics and centers are less common due to the technical complexities involved in ECCO2R.
The demand for ECCO2R devices is bolstered by several factors, including increased healthcare spending, urbanization leading to higher respiratory disease rates, and improved critical care infrastructure. However, challenges such as high costs, limited clinical evidence from extensive trials, and uneven distribution of trained personnel hinder widespread adoption. Currently, ECCO2R technology is primarily utilized in referral or academic medical centers rather than peripheral hospitals.
Strategic Insights
The aging population in the Asia Pacific region is a significant driver of the ECCO2R market. The World Health Organization (WHO) projects that the population aged 60 and over will rise from approximately 1.1 billion in 2023 to around 2.1 billion by 2050, constituting about 22% of the global population. This demographic shift correlates with an increase in chronic respiratory diseases, particularly among older adults who are more susceptible to acute respiratory failure.
Older patients often cannot tolerate the trauma of invasive mechanical ventilation, making ECCO2R a viable alternative or supplement. Studies indicate that ECCO2R can lead to fewer intubations and shorter durations of invasive mechanical ventilation, particularly beneficial for older patients with COPD.
Manufacturers are responding to these demographic and clinical needs through product innovations and clinical research. For instance, ALung Technologies' Hemolung RAS received FDA De Novo approval in 2024 as the first ECCO2R device for adults with reversible acute respiratory failure. This device operates at low blood flow rates, making it less stressful for elderly patients. Additionally, Baxter's PrismaLung+ is being tested for low-flow ECCO2R in ARDS patients.
Country Insights
China is emerging as the leading market for ECCO2R devices in the Asia Pacific region, driven by a rise in ARDS and COPD cases, worsened by air pollution and an aging population. Clinical studies in China have supported the use of ECCO2R in COVID-19-related ARDS cases, demonstrating its effectiveness in managing severe respiratory conditions.
Despite these advancements, challenges remain, including a lack of large-scale clinical trials and the concentration of ECCO2R use in high-tier hospitals. Factors such as device costs, facility requirements, and reimbursement policies are still uncertain, which may limit broader adoption.
Conclusion
In summary, the Asia Pacific ECCO2R devices market is on a robust growth trajectory, with significant contributions from China, Japan, and India. The increasing prevalence of respiratory diseases among the aging population, coupled with innovations in device technology, positions ECCO2R as a critical solution in respiratory care. However, for widespread adoption, further clinical validation, favorable reimbursement frameworks, and enhanced healthcare capacity are essential.
Key Players
Key players in the market include Terumo Corp, Medtronic Plc, Baxter International Inc, LivaNova Plc, Getinge AB, Fresenius Medical Care AG & Co KGaA, Eurosets SRL, Aferetica s.r.l., Medica S.p.A., and ESTOR S.P.A. These companies are focusing on expansion, product innovation, and strategic mergers and acquisitions to enhance their market presence.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Extracorporeal CO2 Removal Devices Market Forecast and Analysis
7. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Extracorporeal CO2 Devices
7.1.1 Overview
7.1.2 Extracorporeal CO2 Devices: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Consumables
7.2.1 Overview
7.2.2 Consumables: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Chronic Obstructive Pulmonary Disease (COPD)
8.1.1 Overview
8.1.2 Chronic Obstructive Pulmonary Disease (COPD): Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Acute Respiratory Distress Syndrome (ARDS)
8.2.1 Overview
8.2.2 Acute Respiratory Distress Syndrome (ARDS): Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - COUNTRY ANALYSIS
10.1 Asia Pacific
10.1.1 Asia Pacific Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Asia Pacific Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.2.2 China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 China: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.1.2.2.2 China: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.1.2.2.3 China: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.2.3.3 Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.2.3.3.2 Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.2.3.3.3 Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.3.4.4 India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 India: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.3.4.4.2 India: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.3.4.4.3 India: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.4.5.5 Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.4.5.5.2 Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.4.5.5.3 Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.5.6.6 South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.5.6.6.2 South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.5.6.6.3 South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.6.7.7 Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.6.7.7.2 Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.6.7.7.3 Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Terumo Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Baxter International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LivaNova Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Fresenius Medical Care AG & Co KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eurosets SRL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aferetica s.r.l.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medica S.p.A.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ESTOR S.P.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET LANDSCAPE
4.1 Market Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - ASIA PACIFIC MARKET ANALYSIS
6.1 Asia Pacific Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Extracorporeal CO2 Removal Devices Market Forecast and Analysis
7. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY PRODUCT
7.1 Extracorporeal CO2 Devices
7.1.1 Overview
7.1.2 Extracorporeal CO2 Devices: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Consumables
7.2.1 Overview
7.2.2 Consumables: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY APPLICATION
8.1 Chronic Obstructive Pulmonary Disease (COPD)
8.1.1 Overview
8.1.2 Chronic Obstructive Pulmonary Disease (COPD): Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Acute Respiratory Distress Syndrome (ARDS)
8.2.1 Overview
8.2.2 Acute Respiratory Distress Syndrome (ARDS): Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET REVENUE ANALYSIS - BY END USER
9.1 Hospitals and Clinics
9.1.1 Overview
9.1.2 Hospitals and Clinics: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Ambulatory Surgical Centers
9.2.1 Overview
9.2.2 Ambulatory Surgical Centers: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. ASIA PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET - COUNTRY ANALYSIS
10.1 Asia Pacific
10.1.1 Asia Pacific Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.1.1 Asia Pacific Extracorporeal CO2 Removal Devices Market Revenue and Forecast and Analysis - by Country
10.1.2.2 China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.1.2.2.1 China: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.1.2.2.2 China: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.1.2.2.3 China: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.2.3.3 Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2.3.3.1 Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.2.3.3.2 Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.2.3.3.3 Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.3.4.4 India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3.4.4.1 India: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.3.4.4.2 India: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.3.4.4.3 India: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.4.5.5 Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4.5.5.1 Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.4.5.5.2 Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.4.5.5.3 Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.5.6.6 South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5.6.6.1 South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.5.6.6.2 South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.5.6.6.3 South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
10.6.7.7 Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6.7.7.1 Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Product
10.6.7.7.2 Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by Application
10.6.7.7.3 Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market Share - by End User
11 COMPETITIVE LANDSCAPE
11.1 Heat Map Analysis by Key Players
11.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
12.1 Overview
12.2 New Product Development
12.3 Merger and Acquisition
12.4 Other Strategic Developments
13 COMPANY PROFILES
13.1 Terumo Corp
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Medtronic Plc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Baxter International Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 LivaNova Plc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Getinge AB
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Fresenius Medical Care AG & Co KGaA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eurosets SRL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Aferetica s.r.l.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Medica S.p.A.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ESTOR S.P.A.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 About The Insight Partners
LIST OF TABLES
Table 1. Asia Pacific Extracorporeal CO2 Removal Devices Market Segmentation
Table 2. List of Vendors
Table 3. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 12. Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 15. India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 21. South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 22. South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 24. Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 25. Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 26. Heat Map Analysis by Key Players
Table 1. Asia Pacific Extracorporeal CO2 Removal Devices Market Segmentation
Table 2. List of Vendors
Table 3. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 5. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 9. China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 12. Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 15. India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 18. Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 21. South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 22. South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 23. Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product
Table 24. Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 25. Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 26. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Asia Pacific Extracorporeal CO2 Removal Devices Market Segmentation - Country
Figure 2. Porter’s Analysis
Figure 3. Ecosystem: Extracorporeal CO2 Removal Devices Market
Figure 4. Asia Pacific Extracorporeal CO2 Removal Devices Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Extracorporeal CO2 Removal Devices Market Share (%) - by Product, 2024 and 2031
Figure 8. Extracorporeal CO2 Devices: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Consumables: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Asia Pacific Extracorporeal CO2 Removal Devices Market Share (%) - by Application, 2024 and 2031
Figure 11. Chronic Obstructive Pulmonary Disease (COPD): Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Acute Respiratory Distress Syndrome (ARDS): Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Others: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Asia Pacific Extracorporeal CO2 Removal Devices Market Share (%) - by End User, 2024 and 2031
Figure 15. Hospitals and Clinics: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Ambulatory Surgical Centers: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Asia Pacific Extracorporeal CO2 Removal Devices Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration
Figure 1. Asia Pacific Extracorporeal CO2 Removal Devices Market Segmentation - Country
Figure 2. Porter’s Analysis
Figure 3. Ecosystem: Extracorporeal CO2 Removal Devices Market
Figure 4. Asia Pacific Extracorporeal CO2 Removal Devices Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Extracorporeal CO2 Removal Devices Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Extracorporeal CO2 Removal Devices Market Share (%) - by Product, 2024 and 2031
Figure 8. Extracorporeal CO2 Devices: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Consumables: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Asia Pacific Extracorporeal CO2 Removal Devices Market Share (%) - by Application, 2024 and 2031
Figure 11. Chronic Obstructive Pulmonary Disease (COPD): Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Acute Respiratory Distress Syndrome (ARDS): Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Others: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Asia Pacific Extracorporeal CO2 Removal Devices Market Share (%) - by End User, 2024 and 2031
Figure 15. Hospitals and Clinics: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Ambulatory Surgical Centers: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Others: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Asia Pacific Extracorporeal CO2 Removal Devices Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 19. China: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Japan: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. India: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Australia: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. South Korea: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Rest of APAC: Asia Pacific Extracorporeal CO2 Removal Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Company Positioning & Concentration
